Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |